Abstract: Impulse control disorders (ICDs), compulsive gambling, and buying, sexual, and eating behaviors are an increasingly recognized serious complication in Parkinson’s disease. Related behaviors include punding (repetitive, purposeless behaviors), dopamine dysregulation syndrome (or compulsive medication overuse), and hobbyism (e.g., compulsive Internet use, artistic endeavors, writing). These disorders adversely affect quality of life, relationships, and caregiver burden and are associated with psychiatric comorbidity.
This activity is only available to AJP CME subscribers.
Don't have a subscription to AJP CME? Subscribe Now!
- AJP Subscriber – 12 Month CME Subscription: $155.00
- Non AJP Subscriber – 12 Month CME Subscription: $310.00
If you have questions about AJP CME subscriptions, please contact firstname.lastname@example.org.
The participant will identify the clinical characteristics of impulse control disruption in Parkinson’s disease and recognize an intervention strategy.
This program is designed for all psychiatrists in clinical practice, residents in Graduate Medical Education programs, medical students interested in psychiatry, and other physicians who wish to advance their current knowledge of clinical medicine.
Estimated Time to Complete
Duration: 1 hour
Begin Date: January 1, 2019
End Date: December 31, 2020
How to Earn Credit
In order to earn CME credit, subscribers should read through the material presented in the article. After reading the article, complete the quiz and submit your evaluation and study hours (up to 1 AMA PRA Category 1 Credit™). A score of 60% or higher is required to receive credit.
The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The APA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Faculty and Planner Disclosures
Title: Impulse Control Disorders in Parkinson’s Disease
Authors: Daniel Weintraub, M.D., Eugenia Mamikonyan, M.S.
Affiliations: The Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia (D.W., E.M.); and the Parkinson’s Disease and Mental Illness Research, Education, and Clinical Centers, Corporal Michael J. Crescenz VA Medical Center, Philadelphia (D.W.).
Disclosures: Dr. Weintraub has received research funding or support from the Alzheimer’s Disease Cooperative Study, the Alzheimer’s Therapeutic Research Initiative, Avid Radiopharmaceuticals, the International Parkinson and Movement Disorder Society, the Michael J. Fox Foundation for Parkinson’s Research, NINDS, Novartis, and the VA; he has received honoraria for consultancy from Acadia, Alkahest, Anavex Life Sciences, BlackThorn Therapeutics, Bracket, the CHDI Foundation, Clintrex, Sunovion, and Theravance Biopharma; he has received license fee payments from the University of Pennsylvania for the Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s Disease (QUIP) and the QUIP–Rating Scale; he has received royalties from Wolters Kluwer; and he has received fees for legal consultation for three lawsuits related to medication prescribing in patients with Parkinson’s disease. Ms. Mamikonyan reports no financial relationships with commercial interests.
Discussion of unapproved or investigational use of products*: No.
*APA policy requires disclosure by CME authors of unapproved or investigational use of products discussed in CME programs. Off-label use of medications by individual physicians is permitted and common. Decisions about off-label use can be guided by scientific literature and clinical experience.
Ned H. Kalin, M.D. (Editor-in-Chief, AJP); Michael D. Roy (Editorial Director, AJP); Michael A. Pogachar (Online Content Manager, Journals).
Dr. Kalin has received research support from NIH and NIMH; has served as a consultant for APA, CME Outfitters, the Pritzker Neuropsychiatric Disorders Research Consortium, the Skyland Trail Advisory Board, and TC MSO; owns stock in Celgene and Seattle Genetics; and received honoraria from Elsevier as co-editor of the journal Psychoneuroendocrinology. Mr. Roy and Mr. Pogachar report no financial relationships with commercial interests.
Optimal System Configuration:
- Flash Player: Adobe Flash Player 10.1+
- Browser: Firefox 3+, Internet Explorer 8.0+, Safari 4.0+, or Google Chrome 7.0+
- Operating System: Windows XP+ or Mac OS X 10.4+
- Internet Connection: 1 Mbps or higher
- Screen Resolution: 1024 x 768 pixels.
- Windows PC:500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16-bit; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 1.1+, Internet Explorer 7.0+, Safari 1.0+, Google Chrome, or Opera
- Macintosh: Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit
For assistance: Contact email@example.com for questions about this course | Contact firstname.lastname@example.org for technical assistance